World stocks decline amid sour economic data, ASX futures down 28 points
US stocks traded mostly lower overnight while oil prices fell as government data highlighted the deep economic impacts of the pandemic.
President Donald Trump added to market uncertainty after announcing that the US elections may be postponed, however he faced an immediate pushback by top Republicans.
On the other side of the Atlantic, European markets fell sharply as poor GDP data in Germany added to the subdued mood, with the Dax falling 3.5% as all 30 companies traded in the red. UK shares followed the market lower.
ASX futures have settled 28 points lower after most markets retreated overnight.
European stocks fall sharply
US markets were somewhat mixed as gains in technology offset broader market declines, however Europe experienced a bloodbath.
The STOXX Europe 600 index ended the day 2.16% lower as most sub-indices declined. The FTSE 100 fell 2.31% to 5,989.99 points while the DAX dropped 3.45% to 12,379.65 points.
US GDP fell a staggering 32.9% annualised rate last quarter, the deepest decline since the government started compiling data. While many analysts forecast such a decline, the market as does not seem to be too bothered by these results.
The S&P 500 fell 0.38% and the Dow Jones declined 0.85%. The Nasdaq rose 0.43% after tech giants including Apple, Facebook or Amazon reported strong earnings results.
Asia-Pacific kicked the day off higher but gains were undone as trading progressed. Japan declined 0.26% and the Hang Seng fell 0.69%.
The Australian share market bucked the trend and finished in the black on Thursday with the ASX 200 benchmark index climbing 0.74% to 6,051.1 points.
The MSCI world equity index fell 2.97 points or 0.53%, to 552.5.
Gold prices retreated from all-time highs and settled at US$1,947.4, still near records. Silver dipped almost 3% after a strong rally in recent weeks.
Most oil contracts fell as WTI crude oil tumbled 2.28% to US$40.33, but Brent managed to eke out a small gain.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.